Alvotech (ALVO) Interest & Investment Income (2021 - 2025)
Alvotech (ALVO) reported Interest & Investment Income of $170.7 million for Q3 2025, up 115.84% on a YoY basis from $79.1 million in Q3 2024, and up 214.37% quarter-over-quarter from -$149.2 million in Q2 2025.
Alvotech (ALVO) Interest & Investment Income (2021 - 2025) Analysis & Trends
Alvotech has reported Interest & Investment Income for 5 years, with the latest figure at $170.7 million in Q3 2025.
- For the quarter ending Q3 2025, Interest & Investment Income rose 115.84% year-over-year to $170.7 million; the trailing twelve-month figure through Sep 2025 stood at $170.7 million (up 115.84% YoY), and the FY2025 full-year result was $198.5 million, up 147.67% from the prior year.
- Interest & Investment Income for Q3 2025 stood at $170.7 million, up from -$149.2 million in the prior quarter.
- The five-year high for Interest & Investment Income was $170.7 million in Q3 2025, with the low at -$149.2 million in Q2 2025.
- Historically, Interest & Investment Income has averaged -$8.2 million across 5 years, with a median of -$4000.0 in 2022.
- Annual changes were most pronounced in 2023 — Interest & Investment Income soared 140.31% — and 2025, when it sank 16131389.91%.
- Alvotech's Interest & Investment Income stood at -$7000.0 in 2021, then surged by 728214.29% to $51.0 million in 2022, then soared by 140.31% to $122.5 million in 2023, then sank by 35.44% to $79.1 million in 2024, then jumped by 115.84% to $170.7 million in 2025.
- The last three Interest & Investment Income figures came in at $170.7 million (Q3 2025), -$149.2 million (Q2 2025), and -$126.3 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Alvotech | 12.20 Mn | -160.16 Mn | -22.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 170.69 Mn |
| Jun 30, 2025 | -149.25 Mn |
| Mar 31, 2025 | -126.31 Mn |
| Sep 30, 2024 | 79.08 Mn |
| Jun 30, 2024 | -80.82 Mn |
| Mar 31, 2024 | 783.00 |
| Aug 31, 2023 | 122.48 Mn |
| Jun 30, 2023 | -122.48 Mn |
| Mar 31, 2023 | 1,226.00 |
| Aug 31, 2022 | 50.97 Mn |
| Jun 30, 2022 | -50.97 Mn |
| Mar 31, 2022 | -4,000.00 |
| Sep 30, 2021 | -7,000.00 |